Scheidt, Germany

Michael Zeppezauer


Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Saarbrucken-Scheidt, DE (1989 - 1993)
  • Auf den Hutten, DE (1998)
  • Scheidt, DE (1996 - 2011)

Company Filing History:


Years Active: 1989-2011

Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Michael Zeppezauer: Pioneering Innovations in Cancer Treatment**

Introduction

Michael Zeppezauer, an accomplished inventor from Scheidt, Germany, has made significant contributions to the field of oncology with his innovative approach to cancer treatment. With a total of six patents to his name, Zeppezauer’s work focuses on therapeutic and diagnostic agents that address the complexities of cancer biology.

Latest Patents

Zeppezauer's most recent patents include groundbreaking technologies aimed at characterizing cancer cells and developing effective treatment strategies. One noteworthy invention is a therapeutic and prophylactic agent for cancer that targets and damages the membranes of cancer cells, specifically those within the blood-forming system. This agent utilizes core histones or their active sequences, which include a range of histone proteins like H1, H2A, H2B, H3, and H4, along with modified variants.

Additionally, Zeppezauer has developed peptides designed for the diagnosis and therapy of systemic lupus erythematosus (SLE). These peptides are crafted from antigenic determinants formed by autoantibodies found in the bodily fluids of SLE patients. His work includes the formation of monoclonal antibodies targeted against these autoantibodies, providing a reliable method for diagnosing SLE and facilitating the production of effective treatments.

Career Highlights

Throughout his career, Zeppezauer has worked closely with notable companies, including Symbiotec Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie. His focus on creating pioneering solutions in the medical field highlights his commitment to innovation.

Collaborations

Zeppezauer's collaborations with esteemed colleagues like Robert Reichhart and Reiner Class have further propelled his inventive contributions. The synergy of ideas and expertise among these professionals exemplifies the power of collaboration in advancing medical research and technology.

Conclusion

Michael Zeppezauer stands out as a notable inventor whose efforts in creating innovative treatments for cancer and systemic lupus erythematosus showcase his dedication to improving patient outcomes. His patents not only reflect his ingenuity but also the potential for future advancements in therapeutic interventions. With ongoing research and collaboration, Zeppezauer's impact on the medical industry is sure to grow, paving the way for new possibilities in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…